Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $100.8400 (1.35%) ($99.7000 - $100.8400) on Mon. Jan. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.97% (three month average) | RSI | 62 | Latest Price | $100.8400(1.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(51%) IWC(50%) | Factors Impacting LGND price | LGND will decline at least -1.485% in a week (0% probabilities). VIXM(-24%) UUP(-17%) VXX(-15%) UNG(-3%) USO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.485% (StdDev 2.97%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $101.11(-0.27%) | 10 Day Moving Average | $101.97(-1.11%) | 20 Day Moving Average | $97.84(3.07%) | To recent high | -4.9% | To recent low | 25.5% | Market Cap | $1.621b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |